ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 806

Estradiol Levels Are Elevated in Older Men with Diffuse Cutaneous SSc and Are Associated with Decreased Survival

DeAnna Baker Frost1, Bethany J Wolf2, Christine Peoples3, Katherine Silver4, Maureen Laffoon5, Thomas A. Medsger Jr.3,6 and Carol A. Feghali-Bostwick4, 1Medicine, Division of Rheumatology and Immunology, Medical University of South Carolina, Charleston, SC, 2Public Health Sciences, Medical University of South Carolina, Charleston, SC, 3Department of Medicine, University of Pittsburgh, Division of Rheumatology and Clinical Immunology, Pittsburgh, PA, 4Department of Medicine, Medical University of South Carolina, Division of Rheumatology and Immunology, Charleston, SC, 5Rheumatology, University of Pittsburgh Medical Center, Pittsburgh, PA, 6Medicine, Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: hormones, skin fibrosis and systemic sclerosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: Systemic Sclerosis and Related Disorders – Clinical Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Systemic sclerosis (SSc) is an autoimmune disease characterized by excessive extracellular matrix deposition (ECM), leading to dermal and internal organ fibrosis. As in other autoimmune diseases, SSc is more prevalent in women. However, men have more severe disease. Considering the sex-based disparity in disease severity, estradiol (E2), an estrogen form with pro-fibrotic effects in different organs, may play a role in SSc pathogenesis. We previously reported that post-menopausal women with diffuse cutaneous (dc)SSc have higher serum E2 levels compared to healthy controls of similar age. Our objective was to examine serum E2 levels in dcSSc males in relation to disease characteristics (i.e. autoantibody profile and internal organ involvement) and its impact on survival.

Methods: We measured serum E2 levels in 83 dcSSc men >50 years old from the University of Pittsburgh Scleroderma Center and healthy controls of similar age. Using statistical modeling, we examined the associations between circulating E2 levels, internal organ involvement, autoantibody profiles, and survival.

Results: Male dcSSc patients had significantly higher serum E2 levels compared to healthy male controls. Male dcSSc patients also had higher serum E2 levels compared to dcSSc post-menopausal women of similar age. Male dcSSc patients with high serum E2 levels had significantly more heart involvement and worse survival. Using Cox regression modeling for risk of death, increasing serum E2 levels in anti-Scl-70 antibody positive dcSSc males were associated with an increased risk of death.

Conclusion: DcSSc male patients have higher levels of E2 compared to healthy controls and dcSSc post-menopausal women. Elevated serum E2 levels in dcSSc males >50 are associated with heart involvement and, if anti-Scl-70 antibody positive, worse survival. Our current study expands on our previous work, implicating E2 in the pathogenesis of SSc-associated fibrosis and extends our findings to an association between E2 levels, internal organ involvement, and overall survival. These data suggest an important role for estrogen imbalance in SSc.


Disclosure: D. Baker Frost, None; B. J. Wolf, None; C. Peoples, None; K. Silver, None; M. Laffoon, None; T. A. Medsger Jr., None; C. A. Feghali-Bostwick, GSK, Biogen, BMS, iBio Inc, 2, 7.

To cite this abstract in AMA style:

Baker Frost D, Wolf BJ, Peoples C, Silver K, Laffoon M, Medsger TA Jr., Feghali-Bostwick CA. Estradiol Levels Are Elevated in Older Men with Diffuse Cutaneous SSc and Are Associated with Decreased Survival [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/estradiol-levels-are-elevated-in-older-men-with-diffuse-cutaneous-ssc-and-are-associated-with-decreased-survival/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/estradiol-levels-are-elevated-in-older-men-with-diffuse-cutaneous-ssc-and-are-associated-with-decreased-survival/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology